| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 160.92B | 154.85B | 146.87B | 146.87B | 118.10B | 119.32B |
| Gross Profit | 108.44B | 106.04B | 102.63B | 105.12B | 88.58B | 93.31B |
| EBITDA | 31.70B | 32.03B | 17.00B | 15.97B | 20.36B | 27.41B |
| Net Income | 17.75B | 17.60B | 7.08B | 5.16B | 10.26B | 15.69B |
Balance Sheet | ||||||
| Total Assets | 262.29B | 225.54B | 207.34B | 222.32B | 218.06B | 226.36B |
| Cash, Cash Equivalents and Short-Term Investments | 127.35B | 144.04B | 129.53B | 138.44B | 133.03B | 149.81B |
| Total Debt | 45.11B | 12.45B | 7.44B | 7.80B | 8.14B | 8.93B |
| Total Liabilities | 86.74B | 44.21B | 31.61B | 38.86B | 32.00B | 36.76B |
| Stockholders Equity | 174.70B | 180.06B | 174.52B | 182.14B | 184.64B | 189.53B |
Cash Flow | ||||||
| Free Cash Flow | 4.86B | 23.77B | 9.76B | 18.88B | 731.00M | 31.35B |
| Operating Cash Flow | 14.49B | 30.26B | 13.22B | 20.85B | 4.04B | 35.46B |
| Investing Cash Flow | -39.60B | -14.49B | -6.85B | -7.35B | -17.44B | -7.95B |
| Financing Cash Flow | 12.69B | -10.38B | -15.73B | -8.33B | -16.63B | -3.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥282.57B | -11.40 | 17.98% | 2.52% | 8.31% | 37.90% | |
69 Neutral | ¥171.54B | 7.96 | 10.05% | 4.61% | 5.86% | 43.24% | |
61 Neutral | ¥136.64B | 97.57 | 3.38% | 2.38% | -10.00% | -87.03% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
60 Neutral | ¥39.72B | 9.53 | ― | 4.06% | 2.95% | 174.57% | |
54 Neutral | ¥65.55B | 111.53 | 1.59% | 2.09% | -9.60% | -69.84% | |
43 Neutral | ¥19.73B | -5.14 | ― | ― | -17.46% | -28.71% |